SD Biosensor to supply 136.9 billion COVID-19 self-test kits with Singapore

[의학신문·일간보사=오인규 기자] SD Biosensor (representative Hyo-geun Lee, Tae-young Heo), a global in vitro diagnostic company, announced on the 21st that it has signed a large-scale contract to supply a COVID-19 self-test kit worth 136.9 billion won to Singapore.

Singapore is one of the representative countries that declared With Corona (step-by-step recovery), and is actively using the COVID-19 self-test kit as a means to preemptively control the spread of the COVID-19 mutant virus.

This Singapore supply contract is the third large-scale supply contract following two large-scale supply contracts in October 2021.

The COVID-19 self-test kit will be distributed to a number of companies through the Singapore government, and will also be supplied through the COVID-19 self-test kit vending machines installed throughout the city.

The STANDARD Q COVID-19 Ag Home Test, which has been recognized for its brand power through successive contracts, is a product that has been officially approved by the Ministry of Food and Drug Safety with a sensitivity of 94.94% and a specificity of 100%, and is not affected by Omicron mutation. It is receiving love calls all over the world.

CEO Heo Tae-young said, “The demand for COVID-19 self-test kits is rapidly increasing around the world due to the spread of the COVID-19 mutant virus. We will continue to do our best to contribute to preventing the spread of the COVID-19 mutant virus as a global in vitro diagnostic company.”